ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.567,14
-0,44%
S&P 500
5.521,52
-1,39%
Dow Jones
40.813,57
-1,30%
Euro vs US Dollar
1,08518
-0,31%
Bitcoin
81.106,66
-3,07%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Atara Biotherapeutics Inc (ATRA) Börsenkurse

Atara Biotherapeutics Inc

Atara Biotherapeutics Inc (ATRA)

NASDAQ
6,86
-0,03
(-0,44%)
Beim Schlusskurs: 14 März 9:00PM
Verzögert um 15 Minuten
6,86
0,00
( 0,00% )
Nach Börsenschluss: 10:16PM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
6,86
Gebot
6,56
Fragen
7,07
Volumen
25.739
6,67 Tagesbereich 7,00
5,40 52-Wochen-Bereich 20,8125
Marktkapitalisierung
39,512M
Handelsende
6,89
Handelsbeginn
6,80
Letzte Trade
5
@
7.0199
Letzter Handelszeitpunkt
22:39:14
Finanzvolumen
US$ 176.561
VWAP
6,8597
Durchschnittliches Volumen (3 Mio.)
217.306
Ausgegebene Aktien
5.759.750
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,14
Gewinn pro Aktie (EPS)
-47,94
Erlöse
8,57M
Nettogewinn
-276,13M

Über Atara Biotherapeutics Inc

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and CAR T ... Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and CAR T Programs. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
www.atarabio.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Atara Biotherapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ATRA. The last closing price for Atara Biotherapeutics was US$6,89. Over the last year, Atara Biotherapeutics shares have traded in a share price range of US$ 5,40 to US$ 20,8125.

Atara Biotherapeutics currently has 5.759.750 shares in issue. The market capitalisation of Atara Biotherapeutics is US$39,68 million. Atara Biotherapeutics has a price to earnings ratio (PE ratio) of -0.14.

ATRA Neueste Nachrichten

Weitere Nachrichten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
07 März 2025
ATRA (-0,44%)

Form 8-K - Current report
Edgar (US Regulatory)
07 März 2025
ATRA (-0,44%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 März 2025
ATRA (-0,44%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 März 2025
ATRA (-0,44%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 März 2025
ATRA (-0,44%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
04 März 2025
ATRA (-0,44%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
04 März 2025
ATRA (-0,44%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
04 März 2025
ATRA (-0,44%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
07 Februar 2025
ATRA (-0,44%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.245-3.448275862077.1057.1755.94651616.49578638CS
4-1.72-20.04662004668.589.055.94721067.22672675CS
12-2.83-29.20536635719.6918.7055.42173069.29964464CS
26-1.48-17.74580335738.3418.7055.41532919.58905045CS
52-10.14-59.64705882351720.81255.445536914.15701549CS
156-215.14-96.9099099099222250.254.965160228557.58443536CS
260-209.89-96.8350634371216.757054.9651332716146.02956646CS

ATRA - Frequently Asked Questions (FAQ)

What is the current Atara Biotherapeutics share price?
The current share price of Atara Biotherapeutics is US$ 6,86
How many Atara Biotherapeutics shares are in issue?
Atara Biotherapeutics has 5.759.750 shares in issue
What is the market cap of Atara Biotherapeutics?
The market capitalisation of Atara Biotherapeutics is USD 39,68M
What is the 1 year trading range for Atara Biotherapeutics share price?
Atara Biotherapeutics has traded in the range of US$ 5,40 to US$ 20,8125 during the past year
What is the PE ratio of Atara Biotherapeutics?
The price to earnings ratio of Atara Biotherapeutics is -0,14
What is the cash to sales ratio of Atara Biotherapeutics?
The cash to sales ratio of Atara Biotherapeutics is 4,66
What is the reporting currency for Atara Biotherapeutics?
Atara Biotherapeutics reports financial results in USD
What is the latest annual turnover for Atara Biotherapeutics?
The latest annual turnover of Atara Biotherapeutics is USD 8,57M
What is the latest annual profit for Atara Biotherapeutics?
The latest annual profit of Atara Biotherapeutics is USD -276,13M
What is the registered address of Atara Biotherapeutics?
The registered address for Atara Biotherapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Atara Biotherapeutics website address?
The website address for Atara Biotherapeutics is www.atarabio.com
Which industry sector does Atara Biotherapeutics operate in?
Atara Biotherapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
RDUSRadius Recycling Inc
US$ 28,63
(109,59%)
42,69k
MRMMEDIROM Healthcare Technologies Inc
US$ 1,17
(88,71%)
4,41M
AAOIApplied Optoelectronics Inc
US$ 25,40
(60,05%)
2,5M
BTOGBit Origin Ltd
US$ 0,3715
(36,13%)
4,16M
PRPLPurple Innovation Inc
US$ 0,825
(24,34%)
3,52M
NAYANAYA Biosciences Inc
US$ 0,2401
(-25,23%)
109,85k
LGCBLinkage Global Inc
US$ 0,1755
(-23,16%)
5,89M
MKDWMKDWELL Tech Inc
US$ 0,3214
(-21,15%)
4,13k
RGCRegencell Bioscience Holdings Ltd
US$ 11,80
(-16,25%)
1,93M
OPALOPAL Fuels Inc
US$ 1,8216
(-16,06%)
11,6k
ICONIcon Energy Corporation
US$ 0,131
(-3,68%)
10,82M
LGCBLinkage Global Inc
US$ 0,1755
(-23,16%)
5,89M
ADTXAditxt Inc
US$ 0,0328
(-1,80%)
5,37M
DGLYDigital Ally Inc
US$ 0,0822
(3,53%)
4,88M
MRMMEDIROM Healthcare Technologies Inc
US$ 1,17
(88,71%)
4,41M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
ATRA
Atara Biotherapeutics
USOTC
LIQQF
Liquid Meta Cap (CE)
AMEX
BBAG
JPMorgan BetaBuilders US...
DOWI
DJIHJN
DJ Industrial Average Ne...
NASDAQ
SYBT
Stock Yards Bancorp
NASDAQ
QQQC
FX
GBPUSD
Sterling vs US Dollar
ASX
WBCHCZ
Westpac Banking
USOTC
FSDK
First Citizens National ... (CE)
COIN
SWTGBP
Swarm City
BIT
G
Generali
NASDAQ
PEGR
Project Energy Reimagine...
BIT
UIJ407
Unicredit Bank
BIT
W93N86
UBS
USOTC
SPNNF
SPENN Technology AS (CE)
USOTC
WWNTF
Want Want China (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten